Edgar Dahl

18PUBLICATIONS
56CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer cell biologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 09, 2025
The Janus Face of SPAG6: Inducing EMT in Luminal Breast Cancer Cells Amidst Widespread Expression Loss in Breast Tumours.

Antonio Sechi, Jolein Mijnes, Sophia Villwock

|Jul 12, 2025
Stratification of Hepatocellular Carcinoma Using <i>N</i><sup>6</sup>-Methyladenosine.

Nan Wang, Jia-Xin Shi, Matthias Bartneck

|Nov 09, 2024
High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis.

Verena J Dreyer, Jia-Xin Shi, Michael Rose

|Jul 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.

Veruschka Albert, Christina Bruss, Deniz Tümen

|Feb 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration.

Jennifer Kosinski, Antonio Sechi, Johanna Hain

|Dec 23, 2023
Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic Cholangiocarcinoma.

Guanwu Wang, Carlos C Otto, Lara R Heij

Pageof 3

Frequent Collaborators

6 joint publications

Michael Rose

5 joint publications

Lara Rosaline Heij

4 joint publications

Ruth Knüchel-Clarke

4 joint publications

Jan Bednarsch